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https://doi.org/10.1016/j.stemcr.2018.03.019SUMMARYA dramatic difference in global DNAmethylation betweenmale and female cells characterizesmouse embryonic stem cells (ESCs), unlike
somatic cells. We analyzed DNAmethylation changes during reprogramming of male and female somatic cells and in resulting induced
pluripotent stem cells (iPSCs). At an intermediate reprogramming stage, somatic and pluripotency enhancers are targeted for
partialmethylation and demethylation. Demethylationwithin pluripotency enhancers often occurs at ESC binding sites of pluripotency
transcription factors. Late in reprogramming, global hypomethylation is induced in a female-specific manner. Genome-wide hypome-
thylation in female cells affects many genomic landmarks, including enhancers and imprint control regions, and accompanies the reac-
tivation of the inactive X chromosome. The loss of one of the two X chromosomes in propagating female iPSCs is associated with
genome-wide methylation gain. Collectively, our findings highlight the dynamic regulation of DNA methylation at enhancers during
reprogramming and reveal that X chromosome dosage dictates global DNA methylation levels in iPSCs.INTRODUCTION
Pluripotent stem cells (PSCs) possess the remarkable abil-
ity to self-renew indefinitely and differentiate into any
cell type of the body, and therefore bear significant po-
tential for cell therapy, disease studies, and fundamental
research. A number of procedures can be used to obtain
PSCs, including the derivation of embryonic stem cells
(ESCs) from the mammalian pre-implantation embryo
and the reprogramming of somatic cells by nuclear trans-
fer or transcription factor overexpression (Takahashi and
Yamanaka, 2006). Considerable effort is being directed at
studying the molecular properties of PSCs including
those obtained following reprogramming of somatic cells
to induced PSCs (iPSCs). Accumulating evidence suggests
that DNA methylation plays a crucial role during reprog-
ramming of somatic cells to iPSCs (Koche et al., 2011).
For example, inhibition of the major DNA methyltrans-
ferase DNMT1 can enhance the efficiency of reprogram-
ming (Mikkelsen et al., 2008). In this context, it is
notable that sex chromosome content influences the
global methylation state in ESCs (Zvetkova et al., 2005).
However, to date the effect of sex chromosomes on
DNA methylation dynamics during reprogramming re-
mains poorly understood.Stem Cell R
This is an open access article under the CGlobal DNA methylation levels differ significantly be-
tween male and female mouse ESC lines (Habibi et al.,
2013; Ooi et al., 2010; Shirane et al., 2016; Zvetkova
et al., 2005). Male ESCs have equivalent global levels of
DNA methylation to female and male differentiated cells,
such as mouse embryonic fibroblasts (MEFs), whereas
female ESCs have up to 75% less DNAmethylation (Habibi
et al., 2013). Compared with male ESCs, demethylation in
female ESCs occurs in most genomic contexts including
regulatory regions such as CpG islands, promoters, en-
hancers, and imprint control regions (ICRs), as well as
repeat regions such as major and minor satellites, long
interspersed nuclear elements (LINEs), and long terminal
repeats (LTRs) (Choi et al., 2017a, 2017b; Habibi et al.,
2013; Hackett et al., 2013; Ooi et al., 2010; Yagi et al.,
2017; Zvetkova et al., 2005).
The global hypomethylation of the female mouse ESC
genome has been attributed to the presence of two active
X chromosomes (Xa), since a gain in overall methylation
takes place after the loss of one of the two X chromosomes
(reaching the XO state) (Choi et al., 2017a; Zvetkova et al.,
2005). The increased dosage of X-linked gene Dusp9 in
XaXa female ESCswas shown to contribute to the hypome-
thylation occurring in female ESCs (Choi et al., 2017a). The
presence of two active X chromosomes in female ESCs waseports j Vol. 10 j 1537–1550 j May 8, 2018 j ª 2018 The Author(s). 1537
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
also shown to delay exit from pluripotency (Schulz et al.,
2014). Altogether, these data indicate that the X chromo-
some status is an important regulator of the DNA methyl-
ation landscape and differentiation dynamics of ESCs.
Reprogramming of female somatic cells to iPSCs induces
the reactivation of the inactiveX chromosome (Xi) (Maher-
ali et al., 2007). Thus, like mouse ESCs, female mouse iPSCs
have two active X chromosomes, which enables them to
undergo random X chromosome inactivation upon differ-
entiation (Maherali et al., 2007; reviewed in Pasque and
Plath, 2015). Notably, the reactivation of the Xi occurs
very late in the reprogramming process, specifically in
those cells that already express critical pluripotency factors
(Pasque et al., 2014). The influence that Xi reactivation (X
chromosome reactivation, XCR) may play on global DNA
methylation during the female reprogramming process re-
mains to be investigated. A comprehensive analysis of DNA
methylation during female and male cell reprogramming
to iPSCs, and the correlation with the X chromosome state,
are critical to clarifying this important point. Our earlier
study that examined DNA methylation of microsatellites
suggested that female iPSCs become hypomethylated as a
result of reprogramming (Maherali et al., 2007), suggesting
that female-specific methylation dynamics may be at play
in reprogramming to pluripotency. Interestingly, a recent
paper showed that female cells undergo a transient global
hypomethylation event during the reprogramming process
but reach a similarly high methylation state as male iPSCs
at the end (Milagre et al., 2017), raising the question of how
these changes in methylation relate to the X chromosome
state.
Analyzing the dynamics of DNAmethylation during the
generation of iPSCs is complicated by the low efficiency
and heterogeneity with which the establishment of iPSCs
takes place. Early in reprogramming, when reprogramming
cultures are thought to be still relatively homogeneous, few
changes in DNA methylation were found while histone
modifications change more dramatically (Koche et al.,
2011; Polo et al., 2012). Moreover, studies that examined
promoters in sorted reprogramming subpopulations or het-
erogeneous reprogramming cultures at various time points
toward the generation of partially reprogrammed cells and
iPSCs suggested that changes in DNA methylation mainly
take place late in reprogramming (Lee et al., 2014; Polo
et al., 2012). For promoters, a gain in DNA methylation
was found to take place more rapidly during reprogram-
ming than loss (Lee et al., 2014). Binding sites for pluripo-
tency-associated transcription factors in ESCs show focal
DNA demethylation early in reprogramming cultures,
resolving into larger hypomethylated regions in the
pluripotent state (Lee et al., 2014). The dynamics of DNA
methylation at key regulatory regions such as cell-type-spe-
cific enhancers remains to be explored during intermediate1538 Stem Cell Reports j Vol. 10 j 1537–1550 j May 8, 2018reprogramming stages. Similarly, whether differences in
DNA methylation exist between male and female cells un-
dergoing reprogramming also remains to be determined.
Currently, most published comprehensive analyses of
DNAmethylation dynamics do not reportedly take X chro-
mosome dosage into account (Milagre et al., 2017).
Here, we set out to define the dynamics of DNA methyl-
ation during the reprogramming of male and female MEFs
to pluripotency. To this end, we analyzed genome-scale sin-
gle-base-pair resolution DNA methylation maps of MEFs,
reprogramming intermediates, and iPSCs, both male and
female, and, for comparison, of male and female ESCs. To
define kinetics andmodes ofmale and female DNAmethyl-
ation reprogramming, we focused our analysis on specific
genomic features such as somatic and pluripotency en-
hancers, promoters, repeat elements, and ICRs in relation
to the timing of XCR and X chromosome content. This
effort led us to reveal targeted changes in DNAmethylation
at enhancer regions in reprogramming intermediates, irre-
spective of sex, and a female-specific, extensive global hy-
pomethylation during reprogramming to iPSCs that occurs
concomitant with XCR and is associated with the presence
of two Xas. Global hypomethylation is reversed as female
iPSCs are propagated and one X chromosome is lost. Our
results reveal that the transcriptional activity and number
of X chromosomes are key features to consider when study-
ing reprogramming and iPSCs.RESULTS
Genome-Scale DNA Methylation Maps during Female
and Male Reprogramming
To define the global DNA methylation state and the dy-
namics of DNA methylation at major genomic landmarks
during female cell reprogramming, we took advantage of
genome-scale methylationmaps generated by reduced rep-
resentation bisulfite sequencing (RRBS) (Meissner et al.,
2008) for specific stages of female cell reprogramming for
our previous analysis of XCR kinetics (Pasque et al.,
2014). In our previous study, these datasets revealed a
high persistence of DNA methylation on CpG islands of
the Xi in late reprogramming intermediates but absence
in iPSCs, consistent with the reactivation of the Xi late in
the reprogramming process after a large number of plurip-
otency genes are activated (Pasque et al., 2014). Specifically,
methylation maps of the female reprogramming time
course were available for starting MEFs, a late intermediate
reprogramming state, and resulting iPSCs (Figure 1A, also
summarized in Table S1). For the late intermediate, we
analyzed cells at day 9 of reprogramming based on the pres-
ence of the cell surface marker stage-specific embryonic an-
tigen 1 (SSEA1) (Polo et al., 2012), thereby circumventing
AC D
B
Figure 1. Genome-Scale Methylation Dynamics during Male and Female Cell Reprogramming
(A) Detailed information of the cell types and reprogramming methods used, and the analysis method for methylation. Further details are
included in Table S1.
(B) Average methylation across listed male and female cell types and reprogramming stages at high CpG-density promoters (HCPs) on the X
chromosome. The Xi signature highlights the hemi-methylation of the inactive X chromosome (Xi) present specifically in female MEFs and
SSEA1+/ reprogramming stages.
(C) RNA FISH analysis of Tsix biallelic expression. The counts are presented as percentage of cells with Tsix signal (monoallelic or biallelic)
that show biallelic Tsix signals. The female iPSC lines analyzed at passage 6 are the same lines as those analyzed at passage 14. The same
lines at passages 5, 7, and 13 were also used in Figure 2E.
(D) PCA for RRBS-derived methylation data, considering male and female MEFs, male and female SSEA1 and SSEA1+ sorted reprogramming
intermediates, male iPSCs, and female XX and XO iPSCs, as well as male and female ESCs. Each color represents a cell type and each spot
represents a biological replicate (different samples). PCA was performed for the mean methylation of non-repetitive autosomal 100-bp
genomic tiles with at least two CpGs covered at 53 or greater.the problem of heterogeneity of bulk reprogramming
cultures. In agreement with previous studies, we have
described that upon re-plating, the SSEA1-positive (+) cell
population preferentially progresses to the iPSC state
compared with the SSEA1-negative () cell population,
and therefore is enriched for cells that can successfully
progress to pluripotency (Pasque et al., 2014; Polo et al.,
2012). We also had the methylation map of the SSEA1
population at day 9 of female reprogramming available
(Pasque et al., 2014) (Figure 1A).In addition, we generated new RRBS datasets for the same
stages of male cell reprogramming to enable the compari-
son between male and female cell reprogramming, and
profiled female iPSCs at different passages to control
for DNA methylation changes that take place over time
in culture after these cell lines are established (Figure 1A,
also summarized in Table S1). We also used different
reprogramming methods and male and female iPSCs
generated in different experiments and laboratories to con-
trol for method- and laboratory-dependent differences inStem Cell Reports j Vol. 10 j 1537–1550 j May 8, 2018 1539
DNA methylation in iPSCs (summarized in Table S1 and
Figure 1A). To this end, iPSCs were generated by retroviral
transduction of MEFs with Oct4 (O), Sox2 (S), Klf4 (K),
with or without cMyc (M), or the addition of doxycycline
(dox) to transgenic MEFs carrying different dox-inducible
polycistronic reprogramming factor cassettes (OSKM or
OKSM) (Table S1 and Figure 1A). To control for sex chromo-
some content and enable a comparison with the global hy-
pomethylation of female ESCs, we also used RRBS-based
methylation datasets for male and female ESC samples
(Pasque et al., 2014). All pluripotent stem cells (PSCs)
were maintained in serum and leukemia inhibitory factor
(S/L) conditions. With these methylation datasets, we
aimed to define methylation dynamics during reprogram-
ming to pluripotency and in established iPSCs at the
genome-scale level, and to determine how it is influenced
by sex chromosome content and the transcriptional dose
of genes on the X chromosome.
Our previous work indicated that early-passage female
iPSCs possess two active X chromosomes due to XCR
very late in the reprogramming process (Maherali et al.,
2007; Pasque et al., 2014). Thus, female SSEA1+ reprogram-
ming intermediates still possess an Xi but newly estab-
lished iPSCs carry two active X chromosomes (Pasque
et al., 2014). We also demonstrated previously that deme-
thylation of CpG islands on the Xi occurs only late in re-
programming, after the day-9 SSEA1+ stage, consistent
with the expression state of the X chromosome (Pasque
et al., 2014). This dynamic is illustrated here by plotting
the average DNA methylation level of promoters with
high CpG content (HCPs) on the X chromosome from
our RRBS datasets, revealing higher methylation in cells
with an Xi including female MEFs and the female day-9
SSEA1+ and SSEA1 reprogramming subpopulations (Fig-
ure 1B). Conversely, all male cell types or reprogramming
intermediates and female iPSC lines displayed much lower
methylation levels of HCPs. These results are consistent
with XCR taking place late during reprogramming to iPSCs,
and demonstrate that the X chromosomes in all female
iPSC and ESC lines are in an active expression state. These
data also demonstrate the completely reprogrammed state
of our iPSC lines.
Female ESCs tend to lose one of the two active X chromo-
somes in culture (Choi et al., 2017b, 2017a; Schulz et al.,
2014; Yagi et al., 2017; Zvetkova et al., 2005), raising the
possibility that X chromosome loss occurred in our iPSCs.
To determine the number of active X chromosomes present
in our female iPSC lines, we used RNAfluorescent in situhy-
bridization analysis (FISH). This analysis allowed us to
determine the proportion of female iPSCs with two active
X chromosomes as judged by biallelic expression of the
X-linked gene Tsix. We found that most female iPSC lines
had low biallelic Tsix count, indicative of X chromosome1540 Stem Cell Reports j Vol. 10 j 1537–1550 j May 8, 2018loss (Figure S1A and Table S1). In contrast, two female
iPSC lines had >50% biallelic Tsix signals indicating the
presence of two active X chromosomes in the majority of
the culture (Figure S1A and Table S1). The female ESC
line used in this analysis was derived from an F1 cross be-
tween two different mouse strains (Musculus/Castaneus),
and was previously shown to maintain two active X chro-
mosomes upon extended culture (Lee and Lu, 1999). To
test whether iPSCs with only one Xa indeed arise from
XaXa iPSCs through continued propagation, we cultured
different newly derived female iPSC lines for several pas-
sages and examined X chromosome number. As previously
shown for ESCs, the presence of two active X chromosomes
in female iPSCs correlated with low passage number, and
over time in culture the cells lose one X chromosome,
becoming XO (Figure 1C) (Choi et al., 2017b; Yagi et al.,
2017; Zvetkova et al., 2005). Therefore, our female iPSC
lines included pluripotent cell lines with one or two active
X chromosomes. We termed these XO and XaXa iPSC lines
for the remaining analyses (Figure S1A and Table S1).
Differences in DNA Methylation in iPSCs Correlate
with the Number of Active X Chromosomes
To assess the methylation state in the reprogramming
stages and different cell types, we first performed principal
component analysis (PCA), focusing specifically on differ-
entially methylated autosomal CpGs (based on Fisher’s
exact test with 5% false discovery rate) for all possible pair-
wise cell type comparisons to avoid any influence from the
differential sex chromosome content and epigenetic state.
The PCA analysis revealed that male and female MEFs clus-
tered together with the male and female SSEA1 and
SSEA1+ reprogramming subpopulations, and a strong sepa-
ration of these from all PSC types (Figure 1D). These results
are in agreement with the absence of major changes in
DNA methylation taking place between MEFs and the
day-9 SSEA1 intermediates and a dramatic reorganization
of DNA methylation between the SSEA1 state and iPSCs
(Knaupp et al., 2017; Lee et al., 2014; Milagre et al., 2017;
Polo et al., 2012).
Notably, in all of our female iPSC lines profiled with
RRBS, the number of active X chromosomes correlated
with differences in DNA methylation. Specifically, iPSCs
and ESCs clustered into two main groups (Figure 1D). The
first group contained male iPSCs and ESCs as well as the
XO female iPSC lines. The second group contained the
female XaXa iPSCs and XaXa ESCs (Figure 1D). Therefore,
differences in DNA methylation correlate with the X chro-
mosome status of iPSCs. These data suggested that the
first principal component, which correlated with the num-
ber of active X chromosomes and captured the separation
of XO/XY and XX ESCs/iPSCs as well as most variation in
methylation (Figure 1D), corresponded to the previously
described global difference in methylation between estab-
lished male and female PSCs or XO and XX female PSCs
(Choi et al., 2017b, 2017a; Habibi et al., 2013; Ooi et al.,
2010; Yagi et al., 2017; Zvetkova et al., 2005). Conversely,
the second principal component corresponded to methyl-
ation differences associated with reprogramming progres-
sion. Thus, sex chromosome content influences DNA
methylation dynamics during reprogramming.
iPSCs with Two Active X Chromosomes Are
Hypomethylated and Gain Male-like Global
Methylation upon X Chromosome Loss
In mouse ESCs the number of active X chromosomes cor-
relates with genome hypomethylation, with XaXa ESCs
displaying global demethylation compared with XY or
XO ESCs, while DNA hypomethylation is typically lost
over time in culture due to the loss of one of the two X
chromosomes (Choi et al., 2017b, 2017a; Habibi et al.,
2013; Hackett et al., 2013; Ooi et al., 2010; Schulz et al.,
2014; Yagi et al., 2017; Zvetkova et al., 2005). To assess
the global dynamics of methylation during female cell re-
programming, we next analyzed the methylation levels
across the genome (Figure 2A). As before, we excluded
sex chromosomes and considered only autosomal CpGs
to not be influenced by any potential methylation
changes on the X chromosome due to XCR. The distribu-
tion of autosomal methylation values was similar across
all cell types, displaying a pattern skewed toward hyper-
methylation. However, compared with the other cell
types, both female XaXa ESCs and iPSCs had a pro-
nounced reduction in highly methylated genomic regions
(those carrying 90%–100% methylation). A clear reduc-
tion in overall methylation in XaXa female ESCs and
iPSCs compared with their male counterparts was also
obvious when plotting the average level of autosomal
methylation (Figure 2B). These data showed that XaXa
iPSCs are globally hypomethylated compared with the
starting female MEFs, SSEA1 and SSEA1+ reprogramming
intermediates, as well as male iPSCs and female XO iPSCs,
with a pattern similar to XaXa ESCs.
To confirm the hypomethylated state of XaXa iPSCs, we
performed two additional assays. First, we measured
5-methylcytosine (5mC) levels by dot blot analysis for
three early-passage female iPSC lines and three male iPSC
lines derived independently, in a different lab, and
using a different reprogramming system (Figure 2C and
Table S1). Second, we analyzed global DNA methylation
levels in these same lines as well as another three indepen-
dent XaXa iPSC lines and three independent male iPSCs
lines by mass spectrometry (Figure 2D and Table S1). In
both cases, female iPSCs showed reduced global levels of
DNA methylation, validating the RRBS approach. There-
fore, hypomethylation in female XaXa iPSCs does notdepend on the reprogramming method used to generate
iPSCs, the lab of origin, or the assay used to measure DNA
methylation. These findings show that during reprogram-
ming female cells transition toward a globally hypomethy-
lated genome and that global hypomethylation occurs very
late in reprogramming, after the SSEA1+ stage. Thus, sex
chromosome content influences DNA methylation dy-
namics and global DNA methylation levels at the end of
the reprogramming process. Consequently, the sex of the
starting cells should be considered when delineating DNA
methylation dynamics during reprogramming and in
iPSCs.
The observation that female XO iPSCs show DNA
methylation levels comparable with those of male iPSCs
suggests that global female-specific hypomethylation is
reversed as a result of X chromosome loss upon passage.
To test this idea, we measured global 5mC and 5-hydroxy-
methylcytosine (5hmC) levels over time bymass spectrom-
etry in cells propagated for several passages during which X
chromosome loss takes place as determined by Tsix RNA
FISH (Figure 1C). Loss of one of the X chromosomes corre-
lated with gain of DNA methylation for both 5mC and
5hmC (Figures 2E and S2A). Thus, iPSCs display the same
strong relationship between the presence of two active X
chromosomes and global hypomethylation as female
mouse ESCs (Habibi et al., 2013; Ooi et al., 2010; Schulz
et al., 2014; Zvetkova et al., 2005). We conclude that global
DNA hypomethylation correlates with the presence of two
active X chromosomes during reprogramming to iPSCs.
In Addition to the Non-repetitive Genome,
Hypomethylation in Female iPSCs Affects the
Repetitive Genome as well as ICRs
One characteristic of the female XaXa ESC genome is hypo-
methylation of repetitive elements (Ooi et al., 2010; Zvet-
kova et al., 2005). We therefore examined the distribution
of methylation across repetitive elements including LINEs,
short interspersed nuclear elements (SINEs), and LTRs. We
found that LINEs, SINEs, and LTRs were hypermethylated
in male and female MEFs, male and female SSEA1 and
SSEA1+ reprogramming stages, as well as in male iPSCs
and ESCs and female XO iPSCs (Figure 3A). These elements
exhibited lower methylation in female XaXa iPSCs and
ESCs, consistent with their XX- and pluripotency-specific
hypomethylation (Figure 3A).
Autosomal CpGs in non-repeat regions display a similar
behavior across reprogramming stages and iPSCs as LINEs,
SINEs, and LTRs (Figure 3B), demonstrating the widespread
extent of the global demethylationwave very late in female
reprogramming and the gain of methylation upon the loss
of one of the two X chromosomes in propagating female
iPSCs. To understand whether hypomethylation in XX
iPSCs and ESCs affects different CpG density outside ofStem Cell Reports j Vol. 10 j 1537–1550 j May 8, 2018 1541
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Figure 2. Global Gain in Genome Methyl-
ation upon Loss of One of the Two X Chro-
mosomes in iPSCs
(A) Histograms showing the distribution of
methylation levels of 100-bp tiles captured
by RRBS genome wide for the indicated male
and female cell types and reprogramming
intermediates. Only 100-bp tiles on auto-
somes, but not on sex chromosomes, with
at least two CpGs at coverage 53 or
greater were considered for this analysis.
The methylation level ranges from 0 (no
methylation) to 1 (100% methylation).
(B) Mean autosomal CpG methylation level
over covered CpGs (1-kb tiles) across auto-
somes in indicated male and female cell
types and reprogramming stages. Two-
tailed unpaired t test, *p < 0.01. Error bars
are SEM. The test was performed on male
iPSCs and XaXa iPSCs only.
(C) Dot blot analysis of 5mC in three female
and three male iPSC lines.
(D) Mass spectrometry analysis of 5mC in
iPSCs. 5mC content is expressed as the
percentage of 5mC in the total pool of
cytosine for six male and five female iPSC
lines. Data are presented as mean + SEM.
Two-tailed unpaired t test, n = 2 experi-
ments, *p < 0.0005.
(E) Mass spectrometry analysis of 5mC in
iPSCs at different passages. 5mC content is
expressed as the percentage of 5mC in the
total pool of cytosine, normalized to the
mean 5mC level in male samples in each
time point analyzed. The average for 3 male
and 2–3 female lines are shown for different
passages. Two-tailed unpaired t test, n = 2
experiments, *p < 0.05, ***p < 0.001; ns,
not significant. The XaXa and XO state of the
cell lines used was quantified for the same
lines in Figure 1C.repeats, we selected all non-repetitive DNA segments that
possess a ratio of observed to expected CpG dinucleotides
(i.e., CpG density) of higher than 0.55 and grouped them
into bins of increasing CpG density. We found that CpG-
rich regions of a CpG density between 0.55 and 0.80 were
generally more methylated than those with a CpG density1542 Stem Cell Reports j Vol. 10 j 1537–1550 j May 8, 2018>0.8 regardless of cell identity (Figures S2B and S2C). More-
over, female XX iPSCs and ESCs carried less methylation
regardless of CpG density (Figures S2B and S2C). Together
these data indicate that the pluripotent female XaXa state
alters DNA methylation levels not only of repeats but also
genome wide and across different CpG densities.
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Figure 3. Changes in Methylation at Repeat Elements, ICRs, and cis-Regulatory Sites during Reprogramming
(A) As in Figure 1C but for LINEs, SINEs, and LTRs.
(B) Histograms showing the distribution of methylation levels of non-repeat CpGs captured by RRBS genome wide for the indicated male
and female cell types and reprogramming intermediates. Only 100-bp tiles on autosomes, but not on sex chromosomes, with at least two
(legend continued on next page)
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We next investigated whether methylation in differen-
tially methylated regions (DMRs) associated with ICRs
was affected in female XX iPSCs or during female cell re-
programming, especially given that they are subject to hy-
pomethylation specifically in female ESCs (Choi et al.,
2017b; Hackett et al., 2013; Yagi et al., 2017). We found
that for DMRs of ICRs in ESCs (Meredith et al., 2015),
methylation was high across all male cell types, starting fe-
male MEFs, and the female SSEA1 reprogramming popula-
tions (Figures 3C and S2D; Table S2). ICR methylation was
drastically depleted in female XX iPSCs toward levels
observed in female ESCs (Figures 3C and S2D; Table S2).
Thus, ICRs are largely resistant to DNA demethylation
throughout reprogramming and become erased as XaXa
iPSCs are established. These results obtained for iPSCs
grown in S/L are reminiscent of imprint erasure upon
dual ERK (mitogen-activated protein kinase/extracellular
signal regulated kinases) and GSK3b (glycogen synthase ki-
nase 3b) inhibition (2i) in XY and XX ESCs, or in S/L XX
ESCs (Choi et al., 2017b; Hackett et al., 2013; Yagi et al.,
2017). Furthermore, X chromosome loss in our female
iPSCs did not completely restore imprint methylation,
despite reacquisition of global DNA methylation (Figures
3C and S2D). Poor developmental potential has recently
been attributed to imprint erasure in XX ESCs (Choi
et al., 2017b; Yagi et al., 2017) and correlate with loss of
Zrsr1 imprint in iPSCs (Chang et al., 2014). Here, we found
evidence of imprint erasure for the imprint control region
of Zrsr1 in female XX and XO iPSCs (Table S2). Together,
these results indicate that imprints are not only erased in
XX iPSCs but also are not re-established upon global
genome remethylation in XO iPSCs, which suggests that
female iPSCs, regardless of the number of Xas, may have
a similarly poor developmental potential as female ESCs
(Choi et al., 2017b; Yagi et al., 2017).
Methylation Changes during Female Reprogramming
at cis-Regulatory Elements
Next, we focused our analysis of DNA methylation on cis-
regulatory sites during female reprogramming. To thisCpGs with coverage >53 across all cell types/reprogramming stages
methylation level ranges from 0 (no methylation) to 1 (100% methyl
(C) Distributions of CpG methylation levels for ICRs, shown as violin
(D) Average autosomal CpG methylation values for various cis-regulato
as male iPSCs for comparison, as indicated. Coverage-weighted mean m
53 or greater. LCPs and HCPs refer to low and high CpG-density prom
(E) Heatmap of changes in average methylation for features shown in (
sorted reprogramming subpopulations. The scale indicates the extent
methylation.
(F) As in (E), except for the transition from female SSEA1 to the fem
(G) As in (E), except for the transition from female SSEA1 and SSEA
male iPSCs, respectively. Note that the color scale is different from (E)
1544 Stem Cell Reports j Vol. 10 j 1537–1550 j May 8, 2018end, we determined average methylation levels (Figure 3D)
in ESC-specific enhancers (Koche et al., 2011), ESC super-
enhancers (Hnisz et al., 2013), binding sites for the tran-
scription factors NANOG (N), OCT4 (O), and SOX2 (S) in
ESCs (OSN binding sites) (Chronis et al., 2017), MEF-spe-
cific enhancers (Koche et al., 2011), low CpG-content pro-
moters (LCPs), HCPs, and CpG islands. Interestingly, we
found that within several of these cis-regulatory regions,
changes in average methylation levels were already
apparent in both SSEA1 subpopulations, and more pro-
nounced in XaXa iPSCs (Figures 3D–3G).
To identify genomic features particularly prone to
methylation changes in the SSEA1+ and SSEA1 reprogram-
ming populations, we analyzed changes in averagemethyl-
ation from female MEFs to the SSEA1 and SSEA1+ reprog-
ramming subpopulations, respectively (Figure 3E). We
also determined changes in average methylation between
the SSEA1 and SSEA1+ reprogramming stages and from
the SSEA1 and SSEA1+ intermediates to the iPSC types
(Figures 3F and 3G). Several conclusions arose from these
analyses: first, we noticed a preferential loss of methylation
within ESC-regulatory regions particularly for ESC super-
enhancers and OSN ESC binding sites in both SSEA1+ and
SSEA1 reprogramming intermediates (Figure 3E). The
smaller prototypical ESC enhancers and LCPs showed
fewer substantial changes in their average methylation
level in the SSEA1 intermediates. Because super-enhancers
play key roles for the maintenance of cell identity and
contain a high number of pluripotency transcription
factor binding sites (Hnisz et al., 2013), methylation
changes in these regulatory regions may be of particular
interest for the mechanistic understanding of somatic cell
reprogramming to iPSCs. The average methylation level
of ESC super-enhancers and OSN binding sites differed
dramatically between MEFs and SSEA1 but only relatively
little between SSEA1 and SSEA1+ cells (Figures 3D and 3E).
Thus, at these sites loss of methylation takes place to a
surprisingly high extent in the female SSEA1 intermedi-
ate. Together these data suggest that ESC super-enhancers
and OSN ESC binding sites initiate their demethylationwere filtered with repeat masker to exclude repeat regions. The
ation).
plots.
ry sites in female reprogramming and female XX and XO iPSCs as well
ethylation was computed for each feature using CpGs with coverage
oters, respectively.
D) for the transition from female MEFs to female SSEA1 and SSEA1+
of loss or gain in average methylation. Numbers represent percent
ale SSEA1+ reprogramming stages.
1+ stages, respectively, to female XaXa iPSCs, female XO iPSCs, and
and (F) but the numbers can be compared directly across (D) to (G).
relatively early in female reprogramming, i.e., before SSEA1
expression is induced. This finding is consistent with the
binding of the reprogramming factors within ESC super-
enhancers already early in reprogramming (Chronis et al.,
2017). Despite methylation changes taking place at the fe-
male SSEA1+/ stages, additional changes in average DNA
methylation in ESC-specific cis-regulatory sites occurred af-
ter the SSEA1+ stage as cells move on toward the XaXa iPSC
state (Figures 3D, 3F, and 3G).
Second, we found thatMEF enhancers became lessmeth-
ylated in the SSEA1 sorted intermediate stage, whereas
they slightly gained methylation in SSEA1+ intermediate
relative to the startingMEFs (Figures 3D and 3E). Thus, cells
that have a lowered ability to progress toward the iPSC state
displayed lower methylation levels at MEF enhancers than
those with an increased propensity to reprogram. These
data indicate that different cis-regulatory sites are differen-
tially affected in the SSEA1+ and SSEA1 female reprogram-
ming stages. Inmale iPSCs, MEF enhancers strongly gained
methylation compared with prior reprogramming stages
(Figures 3D and 3G). Interestingly, in XaXa iPSCs the
methylation level ofMEF enhancerswas reduced compared
with the SSEA1+ reprogramming intermediate, consistent
with the globally hypomethylated state of these cells (Fig-
ures 3F and 3G). However, these sites maintained a higher
methylation level in XaXa iPSCs than in any other ele-
ments analyzed (Figure 3D).
Third, for the average methylation levels of HCPs and
CpG islands, little change was apparent throughout re-
programming, consistent with constitutive hypomethyla-
tion of CpG-rich regions (Figures 3D–3G, S2B, and S2C:
CpG density at 0.8 and higher).
Fourth, we observed that ESC-specific cis-regulatory sites,
MEF enhancers, and LCPs were more strongly demethy-
lated in female XaXa iPSCs compared with female XO
iPSCs and male iPSCs (Figures 3D and 3G). The loss of the
X chromosome in propagating female iPSCs (XO iPSCs)
increased methylation within these genomic regions to
an average level similar to that in male iPSCs (Figures 3D,
3F, and 3G). MEF enhancers displayed the most pro-
nounced increase in methylation level in male iPSCs and
XO iPSCs compared with XaXa iPSCs (Figures 3D and
3G), consistent with their silent state in pluripotent cells.
Conversely, even in male iPSCs, ESC-specific cis-regulatory
sites displayed a methylation level lower than in SSEA1
subpopulations, suggestive of greater binding by transcrip-
tion factors at these regions in the pluripotent state (Figures
3D, 3F, and 3G). These data therefore indicate that global
female demethylation also affects cis-regulatory elements
in female iPSCs as a result of the presence of two active X
chromosomes and is subsequently reversed upon X chro-
mosome loss, but the extent of this reversal differs among
cis-regulatory sites.In summary, we conclude that methylation changes at
cis-regulatory regions already begin before the induction
of the pluripotent state in female reprogramming, and
that methylation dynamics during reprogramming and in
propagated female iPSCs differ according to the type of
genomic elements considered and the number of active X
chromosomes. In intermediate female reprogramming
stages, changes are enriched at cis-regulatory regions that
are critical to maintain the somatic and pluripotency tran-
scriptional programs. Our results indicate that somatic and
pluripotency enhancers already adopt some of the charac-
teristics of their pluripotency state early in female reprog-
ramming, before the global and female-specific hypome-
thylation wave occurs in the process.
Single-CpG-Level Methylation Changes during
Reprogramming
To further analyze the methylation changes within cis-reg-
ulatory sites, we next turned to the analysis of single-CpG-
resolutionmethylationmeasurements provided by RRBS to
define methylation changes during reprogramming. This
analysis enabled us to assess changes in DNA methylation
at single CpG resolution, which could be masked in aver-
ages. To identify single-CpG-level methylation variation,
we performed k-means clustering of all differentially meth-
ylated CpGs within selected genomic features, including
MEF enhancers, ESC super-enhancers, ESC enhancers,
and NANOG binding sites in ESCs, to group single CpGs
with similar changes during female reprogramming and
in various iPSCs (Figures 4A, 4B, S3A, and S3B). This anal-
ysis further defined the dynamic regulation of DNA
methylation with single-CpG resolution within enhancers
during female reprogramming and revealed expected as
well as unexpected single-CpG-level DNA methylation
changes.
Considering MEF enhancers (Figure 4A), we found that
single CpGs in several clusters gained methylation toward
the pluripotent state, as expected from averages measure-
ments. However, we also resolved different clusters of sin-
gle CpGswith differentmethylation kinetics during female
reprogramming, becoming demethylated in the SSEA1
cell population and hypermethylated in the SSEA1+ sub-
population (cluster 8), or more methylated only in XO
and XY PSCs (clusters 3, 4, and 6). Other CpGs were ectop-
ically demethylated in female XaXa iPSCs (clusters 1 and 2)
or in XaXa iPSCs and SSEA1 and SSEA1+ intermediates,
respectively (clusters 5 and 7), which may contribute to
the reprogramming state of these cells. We conclude that
CpG-specific and reprogramming stage-specific changes
in DNA methylation take place throughout female reprog-
ramming. This highlights the importance of examining
single-CpG-level DNA methylation during the reprogram-
ming process.Stem Cell Reports j Vol. 10 j 1537–1550 j May 8, 2018 1545
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Figure 4. Single-CpG-Based Analysis of Methylation during Reprogramming
(A) Heatmap showing k-means clustering of single-CpG methylation values located within MEF enhancers across all chromosomes in the
indicated cell types and reprogramming stages (left). Violin plots (right) show the distribution of CpG methylation levels for each cluster
across all samples. The number of CpGs in each cluster is also given.
(B) As in (A), but for ESC super-enhancers. In addition, the proportion of CpGs overlapping O, S, N ESC binding sites, or those sites co-
bound by OSN (OSN) in ESCs, within each cluster, is indicated.
(C) RRBS data depicting a CpG overlapping with an OSN ESC binding site at the Dppa4 locus. The data show a focal loss of DNA methylation
in the SSEA1+ intermediate but not in starting MEFs or SSEA1 sorted cells. The demethylated region is even further expanded in PSCs.
(D) As in (C), except for the Tdgf1 locus where CpG demethylation in specific to the female SSEA1+ intermediates.Within ESC super-enhancers during female cell reprog-
ramming (Figure 4B), a large proportion of CpGs was
constitutively hypomethylated (clusters 1 and 2). The re-
maining CpGs covered in our RRBS analysis in all samples
started with higher methylation in MEFs, which decreased
toward XaXa iPSCs (clusters 3–8), as expected from average
measurements (Figure 3C). For a large fraction of these
CpGs, methylation was detected in XO and male iPSCs,
and their methylation level was lower in XaXa iPSCs
compared with XO or male iPSCs (clusters 5–8), indicating
that they were subject to female-specific hypomethylation
in XaXa iPSCs, which is reset to the male iPSC level upon
loss of the second X chromosome. A decrease in methyl-1546 Stem Cell Reports j Vol. 10 j 1537–1550 j May 8, 2018ation was already apparent in the female SSEA1 or
SSEA1+ subpopulations, respectively, or both (clusters
3–6), indicative of early loss of methylation of a portion
of CpG sites within ESC super-enhancers (Figure 4B). We
also found a CpG associated with the pluripotency gene
Dppa4 that lost methylation in the SSEA1+ intermediates,
but not in SSEA1 cells or in neighboring CpGs (Figure 4C).
An additional example in SSEA1+ intermediates was a cis-
regulatory site of the Tdgf1 gene located within an ESC su-
per-enhancer, which was demethylated in female SSEA1+
reprogramming intermediates but not in SSEA1 cells (Fig-
ure 4D). Finally, cluster 4 had, unexpectedly, increased
methylation specifically in female SSEA1+ cells (Figure 4A).
While the relevance of this observation is not clear, many
of these sites were associated with known pluripotency
genes such as Dppa3, Esrrb, Nanog, Otx2, Sox2, Tbx3, Utf1,
and Nr5a2 (not shown). We made similar observations for
ESC enhancers (Figures S3A and S3B).
To detect male DNA methylation dynamics, we also per-
formed k-means clustering withmale reprogramming sam-
ples only (Figures S3C–S3E). We were not able to directly
compare the sameCpG sites inmale and female reprogram-
ming intermediates due to the limited overlap in RRBS
datasets. Nevertheless, we could detect single-CpGmethyl-
ation changes in male reprogramming with a similar
pattern as for female reprogramming with the exception
of the global, female-specific DNA hypomethylation (Fig-
ures 4C and S3C–S3E). We conclude that CpG-specific
and reprogramming stage-specific changes in enhancer
DNA methylation take place during male and female re-
programming to iPSCs.
Dynamic Methylation in ESC Super-Enhancers and
ESC Enhancers Occurs at Pluripotency Transcription
Factor Binding Sites in Reprogramming Intermediates
Irrespective of Sex
To define whether changes in DNA methylation during re-
programming correlate with pluripotency transcription fac-
tor binding sites, we assessed the overlap of ESC binding
sites of OCT4, SOX2, and NANOG, with our female and
male CpG methylation ESC super-enhancer and ESC
enhancer clusters (Figures 4B, S3A, S3D, and S3E). Interest-
ingly, ESC super-enhancer CpGs in clusters 1 and 3–7,
which displayed different trajectories of methylation
changes fromMEFs to pluripotency, were located in regions
bound byOCT4, SOX2, andNANOG in ESCs (Figure 4B). Of
note, CpGs that become demethylated in SSEA1 cells and/
or SSEA1+ cells (clusters 4–6) are most strongly enriched for
OSN binding in ESCs. OSN binding sites in ESC super-en-
hancers and ESC enhancers also showed single-CpG DNA
methylation changes inmale reprogramming intermediates
(Figure S3D). Surprisingly, methylation gains in SSEA1+ in-
termediates correlated both in male and female reprogram-
ming with strong pluripotency factor transcription factor
binding in iPSCs (cluster 4 in female reprogramming, Fig-
ure 4B; and cluster 6 in male reprogramming, Figure S3D;
also see cluster 6, Figure S3D; cluster 1, Figure S3E). Given
the CpG methylation changes at OSN binding sites within
ESC super enhancers, methylation dynamics similar to
those of CpGs in ESC super-enhancers were seen for CpGs
within ESC binding sites of the pluripotency factor NANOG
(Figure S3B). Thus, at ESC super-enhancers and ESC en-
hancers, several ESC binding sites of OSN change methyl-
ation in different directions early in reprogramming.
We conclude that changes in single-CpG methylation
occur at cis-regulatory elements such as ESC enhancers atthe ESC binding sites of pluripotency transcription factors
in a reprogramming stage-specific manner, irrespective of
sex. Thus, changes in methylation early in reprogramming
appear to be initiated at focal sites of high putative regula-
tory function, in both male and female cells, suggesting
important consequences for our mechanistic understand-
ing of reprogramming of cell identity.DISCUSSION
Our results indicate that the analysis of DNA methylation
in reprogramming needs to consider the sex chromosome
genotype. Reprogramming to iPSCs leads to the global hy-
pomethylation of the female genome, which is not seen in
male iPSCs. Since two active X chromosomes are acquired
late during female cell reprogramming (Maherali et al.,
2007), and hypomethylation is seen in female XX iPSCs
but not in late female SSEA1+ intermediates, we propose
that the reactivation of the inactive X chromosome triggers
female-specific global hypomethylation during female cell
reprogramming. Importantly, global hypomethylation of
XX iPSCs does not depend on the reprogramming method
used. For female mouse ESCs, it was shown that loss of one
of the two active X chromosomes triggers a rapid remethy-
lation of the genome to the male ESC level (Zvetkova et al.,
2005). Our results are in line with similar events happening
in female iPSCs during extended passaging, but not
during reprogramming.Mechanistically, hypomethylation
is likely due to the double dose of one ormore X-linked fac-
tors responsible for inhibiting DNAmethyltransferases and
inhibiting pro-differentiation signals including the ERK
and GSK3b pathways (Schulz et al., 2014). One such candi-
date is Dusp9, recently shown to contribute to the control
of genome hypomethylation in female XX ESCs (Choi
et al., 2017a). We envision a model in which XCR leads
to a double dose ofDusp9, thereby inhibiting DNAmethyl-
transferases (Choi et al., 2017a), followed by decreased
Dusp9 dosage due to X chromosome loss, resulting in
genome remethylation. In summary, XCR followed by X
chromosome loss in female iPSCs explains the sex-specific
DNA methylation events seen in our study. These observa-
tions might explain some of the changes described in a
recent study of DNA methylation during reprogramming
that did not examine the state of the X chromosome (Mila-
gre et al., 2017). We have not excluded the possibility that
X chromosome loss takes place as a result of global DNAhy-
pomethylation. Collectively, our results highlight the sex
chromosome content of a somatic cell as a critical factor
to consider for studying DNA methylation changes during
reprogramming. Importantly, it is not just sex that matters,
but the number of active X chromosomes relative to auto-
somes (X chromosome dosage).Stem Cell Reports j Vol. 10 j 1537–1550 j May 8, 2018 1547
Several studies have been carried out to assess the
methylation status of ICRs in iPSCs (Chang et al., 2014;
Kim et al., 2013; Stadtfeld et al., 2010, 2012; Takikawa
et al., 2013). Most agree that imprints can become deregu-
lated inmouse iPSCs, but no consensus exists on the extent
and variability of imprint erasure in iPSCs (Takikawa et al.,
2013). Our results suggest that some of the reported differ-
ences in ICRmethylation could be explained by differences
in X chromosome status and sex and that imprints in fe-
male iPSCs are prone to deregulation. Notably, we found
evidence of imprint erasure in female XX iPSCs, which
was not fully re-established after global methylation gain
due to X chromosome loss. Our results are consistent
with recent reports in ESCs inwhich imprint erasure driven
by MAPK inhibition is irreversible (Choi et al., 2017b;
Hackett et al., 2013; Yagi et al., 2017). Imprint erasure in fe-
male iPSCs could therefore have important functional im-
plications for the differentiation and function of female
iPSCs and the specialized cell types derived from them.
One prediction is that female iPSCs, in early or late passage,
will generate chimeras with decreased efficiency over male
iPSCs, which remains to be tested.
Our discovery of changes in DNA methylation at inter-
mediate reprogramming stages is an important step toward
understanding erasure of epigenetic memory during cell
fate reprogramming. Such changes appear to be, at least
in part, independent of sex, in agreement with a recent
report (Milagre et al., 2017). Partial DNA demethylation
in SSEA1+ intermediates was also confirmed using tradi-
tional bisulfite sequencing analysis for Dppa3 (Figure S4A).
Because our male and female SSEA1 datasets were gener-
ated independently, a direct comparison is difficult,
warranting a careful comparison of male and female epige-
nomes throughout reprogramming and in iPSCs. Never-
theless we found instances in which a single CpG within
an ESC super-enhancer became hypomethylated in both
female SSEA1 and SSEA1+ intermediates, as well as in fe-
male iPSCs, but not in female MEFs, for example bordering
the miR290–295 cluster (Figure S4B).
Our study reveals that key regulatory regions associated
with the control of cell identity genes are prone to changes
in DNA methylation in reprogramming intermediates in
bothmale and female cells. Previous reports usingmicroar-
rays or bisulfite sequencing showed that promoter methyl-
ation is reset at a very late stage of reprogramming (Knaupp
et al., 2017; Polo et al., 2012), consistent with analysis of
methylation during human reprogramming (Cacchiarelli
et al., 2015). Another study revealed global indiscriminate
remethylation of somatic enhancers in human iPSCs
regardless of somatic origin (Nissenbaum et al., 2013),
which will be interesting to also test in the mouse. Never-
theless, we found that many CpGs, particularly those in
enhancer elements, which are thought to play key roles1548 Stem Cell Reports j Vol. 10 j 1537–1550 j May 8, 2018for the maintenance of cell identity (Hnisz et al., 2013),
change their methylation status earlier in reprogramming.
This observation is in agreement with the finding that
changes in methylation at intermediate reprogramming
stages take place for several promoters and ESC binding
sites of pluripotency transcription factors (Lee et al.,
2014). We speculate that these methylation changes coin-
cide with progressive changes in chromatin state and tran-
scription factor access, allowing, for instance, the engage-
ment of the reprogramming factors at their ESC target
sites at intermediate stages of reprogramming. This idea is
supported by early engagement of a subset of sites by
OCT4, SOX2, and C-MYC at pluripotency super-enhancers
at 48 hr of reprogramming (Chronis et al., 2017).
As reprogramming to iPSCs proceeds through multiple
stages (Knaupp et al., 2017; Pasque et al., 2014), we antici-
pate that the isolation of reprogramming intermediates in
these distinct stages of reprogramming combined with
genome-wide analysis of methylation at the population
or single-cell level will reveal additional dynamic methyl-
ation events during male and female somatic cell reprog-
ramming to pluripotency. The importance of purifying
cells at specific stages of reprogramming is underscored
by our finding that the average loss of methylation at
OSN transcription factor binding sites in SSEA1 as
opposed to SSEA1+ intermediates is similar on average yet
occurs at different genomic locations. Moreover, it is
also possible that several cycles of DNAmethylation/deme-
thylation take place at a given site during reprogramming.
A detailed analysis of DNA methylation dynamics in
comparison with changes in histone modifications and
reprogramming factor binding at various male and female
reprogramming stages should also reveal how and if DNA
methylation affects reprogramming events.
Our findings also may have important implications for
the understanding of human naive pluripotency in rela-
tion to regenerative medicine applications and disease
modeling, given that naive-like human ESCs show global
hypomethylation and imprint erasure (Theunissen et al.,
2016). The link between the status of the X chromosomes
and human pluripotency is also of considerable current in-
terest. Human PSCs grown in primed conditions have an
inactive X chromosome, which is unstable due to erosion
of X inactivation (Mekhoubad et al., 2012). Growing hu-
man ESCs in naive-like conditions induces XCR and the
cells undergo non-random X chromosome inactivation
when induced to differentiate (Theunissen et al., 2016).
Whether X chromosome dosage influences the transcrip-
tional and epigenomic landscape of human PSCs in the
naive state is not clear. There have also been reports of
sex-specific differences in gene expression and pro-
grammed cell death in human PSCs cultured in the primed
state (Bruck et al., 2013; Ronen and Benvenisty, 2014).
Understanding the interplay between the activity of sex
chromosomes and pluripotency provides an exciting
avenue for future studies.EXPERIMENTAL PROCEDURES
Cell Culture and Mice
ESCs were grown in ESC culture medium (Supplemental Experi-
mental Procedures) and MEFs were cultured in DMEM with the
same components as for ESC medium except for leukemia inhibi-
tory factor and with 10% fetal bovine serum. All animal work car-
ried out in this study is covered by a project license approved by the
KU Leuven Animal Ethics Committee.
Reprogramming Stages
Reprogramming and the isolation of reprogramming intermedi-
ates was previously described (Pasque et al., 2014). iPSCs were
picked fromday-21 reprogramming cultures and grown in ESCme-
dium on feeders. Table S1 lists all the cell lines, replicates, reprog-
ramming method, and passage number of the primary and estab-
lished cell lines used in this study. Additional information is
included in Supplemental Experimental Procedures.
RRBS and Data Analysis
The generation of RRBS data used in this study was described previ-
ously (Pasque et al., 2014). At least two RRBS biological replicate li-
braries were constructed for each cell type analyzed, and up to four
biological replicates for female MEFs and female ESCs were utilized
(Table S1). Some of these datasets (GEO:GSE58109)were used previ-
ously to determine the methylation state of CpG islands on the X
chromosomeindifferent reprogrammingstages (Pasqueetal., 2014).
ACCESSION NUMBERS
The GEO accession numbers for the RRBS data used in this study
are GEO: GSE58109 and GSE111042.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and two tables and can be found with
this article online athttps://doi.org/10.1016/j.stemcr.2018.03.019.
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